We are live on ! Find out more
PMAM

Picton Mahoney Asset Management Portfolio holdings

AUM $13.5B
1-Year Est. Return 51.47%
This Fund
S&P 500
This Quarter Est. Return
+1.64%
1 Year Est. Return
+51.47%
3 Year Est. Return
+209.24%
5 Year Est. Return
+374.21%
10 Year Est. Return
+1,935.98%
AUM
$2.71B
AUM Growth
-$726M
Cap. Flow
-$570M
Cap. Flow %
-21.08%
Top 10 Hldgs %
16.74%
Holding
1,084
New
200
Increased
106
Reduced
127
Closed
187
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARTA
576
DELISTED
Artisan Acquisition Corp. Class A Ordinary Shares
ARTA
$644K 0.02%
+64,916
New +$632K
DMTK
577
DELISTED
DermTech, Inc. Common Stock
DMTK
$641K 0.02%
19,984
IWN icon
578
iShares Russell 2000 Value ETF
IWN
$14.7B
$640K 0.02%
4,000
PAAS icon
579
Pan American Silver
PAAS
$19.8B
$575K 0.02%
+796,743
New +$20.8M
IVE icon
580
iShares S&P 500 Value ETF
IVE
$50.2B
$524K 0.02%
3,600
GRND icon
581
Grindr
GRND
$2.71B
$507K 0.02%
50,000
FTVIU
582
DELISTED
FinTech Acquisition Corp. VI Units
FTVIU
$500K 0.02%
50,000
ARYE
583
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$494K 0.02%
+50,000
New +$497K
FICVU
584
DELISTED
Frontier Investment Corp Units
FICVU
$493K 0.02%
+50,000
New +$495K
EMBKW
585
DELISTED
Embark Technology, Inc. Warrants
EMBKW
$472K 0.02%
442,046
+109,066
+33% +$138K
HCCCU
586
DELISTED
Healthcare Capital Corp. Unit
HCCCU
$471K 0.02%
46,283
-153,717
-77% -$1.56M
KCAC
587
DELISTED
Kensington Capital Acquisition Corp. II
KCAC
$414K 0.02%
50,000
PKBO
588
DELISTED
Peak Bio, Inc. Common Stock
PKBO
$392K 0.01%
+40,000
New +$388K
SNAP icon
589
Snap
SNAP
$8.83B
$384K 0.01%
5,200
MITK icon
590
Mitek Systems
MITK
$835M
$373K 0.01%
+20,200
New +$410K
EWU icon
591
iShares MSCI United Kingdom ETF
EWU
$4.13B
$368K 0.01%
11,420
+1,640
+17% +$53.9K
SPY icon
592
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$814B
$344K 0.01%
800
+600
+300% +$265K
PLXP
593
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$332K 0.01%
+17,200
New +$301K
LOW icon
594
Lowe's Companies
LOW
$122B
$304K 0.01%
1,500
-200
-12% -$39.9K
AGCB
595
DELISTED
Altimeter Growth Corp 2
AGCB
$297K 0.01%
30,000
EWH icon
596
iShares MSCI Hong Kong ETF
EWH
$1.21B
$230K 0.01%
9,590
+2,150
+29% +$55.3K
IWM icon
597
iShares Russell 2000 ETF
IWM
$82.4B
$230K 0.01%
1,050
+150
+17% +$33.3K
EWA icon
598
iShares MSCI Australia ETF
EWA
$1.45B
$227K 0.01%
9,150
+1,470
+19% +$38K
CZR icon
599
Caesars Entertainment
CZR
$6.06B
$225K 0.01%
2,000
+300
+18% +$29.3K
URA icon
600
Global X Uranium ETF
URA
$6.33B
$214K 0.01%
9,000
+4,500
+100% +$95.8K

Similar funds

Picton Mahoney Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Picton Mahoney Asset Management held 1,084 positions worth $2.71B, down 21% from $3.43B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Picton Mahoney Asset Management withdrew a net $570M in Q3 2021, closing 187 positions and reducing 127 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $46.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Picton Mahoney Asset Management opened a new position in Medallia, Inc. worth $26.2M.

  • Picton Mahoney Asset Management's largest Q3 2021 buy was Medallia, Inc.: 775,000 shares worth $26.2M.
  • Picton Mahoney Asset Management added most to Dragoneer Growth Opportunities Corp. II Class A Ordinary Shares in Q3 2021, an estimated $7.94M increase.
  • Picton Mahoney Asset Management's biggest Q3 2021 reduction was Amazon, cutting an estimated $16.5M.
  • Picton Mahoney Asset Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $46.8M.
  • Picton Mahoney Asset Management's ten largest holdings make up 17% of its $2.71B portfolio in Q3 2021.
  • Picton Mahoney Asset Management opened 200 new positions and closed 187 in Q3 2021.
  • Picton Mahoney Asset Management's portfolio value fell 21% quarter-over-quarter to $2.71B.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2021, filed 9 Nov 2021.